Arcutis Biotherapeutics, Inc.
ARQT
$12.59
-$0.85-6.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.79M | -41.54M | -52.33M | -35.38M | -66.28M |
| Total Depreciation and Amortization | 458.00K | 1.43M | 351.00K | 358.00K | 385.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.15M | 9.22M | 11.13M | 8.86M | 9.24M |
| Change in Net Operating Assets | -1.57M | -3.80M | -4.27M | -5.44M | 411.00K |
| Cash from Operations | -748.00K | -34.69M | -45.12M | -31.60M | -56.24M |
| Capital Expenditure | 0.00 | -143.00K | -- | -- | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.88M | 84.92M | -62.14M | -28.70M | -62.18M |
| Cash from Investing | 34.88M | 84.78M | -62.14M | -28.70M | -62.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00M | -- | -- | -- | -- |
| Issuance of Common Stock | 2.59M | 394.00K | 1.46M | 161.76M | 99.29M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.41M | 394.00K | 1.46M | 161.76M | 99.29M |
| Foreign Exchange rate Adjustments | -234.00K | 98.00K | -26.00K | -73.00K | 68.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.52M | 50.58M | -105.83M | 101.39M | -19.07M |
